검색어 : 통합검색[Dayton Jonathan]
총 324건 중 324건 출력
, 33/33 페이지
-
321
-
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
-
Isa, Flonza;
Forleo-Neto, Eduardo;
Meyer, Jonathan;
Zheng, Wenjun;
Rasmussen, Scott;
Armas, Danielle;
Oshita, Masaru;
Brinson, Cynthia;
Folkerth, Steven;
Faria, Lori;
Heirman, Ingeborg;
Sarkar, Neena;
Musser, Bret J.;
Bansal, Shikha;
O'Brien, Meagan P.;
Turner, Kenneth C.;
Ganguly, Samit;
Mahmood, Adnan;
Dupljak, Ajla;
Hooper, Andrea T.;
Hamilton, Jennifer D.;
Kim, Yunji;
Kowal, Bari;
Soo, Yuhwen;
Geba, Gregory P.;
Lipsich, Leah;
Braunstein, Ned;
Yancopoulos, George D.;
Weinreich, David M.;
Herman, Gary A.;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Celerion, Lincoln, NE, USA;
Celerion, Tempe, AZ, USA;
Benchmark Research, Sacramento, CA, USA;
Central Texas Clinical Research, LLC, Austin, TX, USA;
Midwest Clinical Research Center, LLC, Dayton, OH, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;
Regeneron Pharmaceuticals, Inc.,;
(International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
v.122,
2022,
pp.585-592)
-
322
-
ECOG-ACRIN E1411 randomized phase 2 trial of bendamustine-rituximab (BR)-based induction followed by rituximab (R) ± lenalidomide (L) consolidation for Mantle cell lymphoma: Effect of adding bortezomib to front-line BR induction on PFS.
-
Smith, Mitchell Reed;
Jegede, Opeyemi;
Martin, Peter;
Till, Brian G.;
Parekh, Samir S.;
Yang, David T;
Kostakoglu, Lale;
Casulo, Carla;
Bartlett, Nancy L.;
Caimi, Paolo Fabrizio;
Al Baghdadi, Tareq;
Maddocks, Kami J.;
Romer, Mark D.;
Inwards, David James;
Lerner, Rachel E.;
Wagner, Lynne I.;
Little, Richard F.;
Friedberg, Jonathan W.;
Leonard, John Paul;
Kahl, Brad S.;
GW University, Washington, DC;
;
Dana Farber Cancer Institute, Boston, MA;
;
Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY;
;
Fred Hutchinson Cancer Rsrch Ctr, Seattle, WA;
;
Mount Sinai, New York, NY;
;
University of Wisconsin Carbone Cancer Center, Madison, WI;
;
University of Virginia, Charlottesville, TN;
;
University of Rochester Medical Center-James P. Wilmot Cancer Center, Rochester, NY;
;
Washington University School of Medicine in St. Louis and Siteman Cancer Center, St. Louis, MO;
;
Adult Hematologic Malignancies and Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH;
;
IHA Hematology Oncology Consultants, Ypsilanti, MI;
;
Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH;
;
Good Samaritan Hospital-Dayton, Kettering, OH;
;
Division of Hematology, Mayo Clinic, Rochester, MN;
;
Frauenshuh Cancer Center and Park Nicollet Institute, Minn;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.39,
2021,
pp.7503-7503)
-
323
-
Book Reviews
-
Spall, Richard F.;
Austen, Ralph A.;
Austen, Ralph A.;
Louis, Wm. Roger;
Mcclellan, Charles W.;
Aksan, Virginia H.;
Mahdi, Ali Akbar;
Simpson, Brooks D.;
Braeman, John;
Ferrer, Ada;
Varon, Elizabeth R.;
Smith, Michael O.;
Walker, William O.;
Gaskins, Susanne Teepe;
Morgan, David T.;
Jennings, Francis;
O'donnell, Mabry M.;
Keyes, Jonathan J.;
Couvares, Francis G.;
Hattaway, Herman;
Winter, Thomas;
Harmond, Richard;
Boyd, Steven R.;
Winter, Thomas;
Cahall, Michael C.;
Wilson, Raymond;
Fletcher, Marvin E.;
Bakken, Gordon Morris;
Alexander, Roberta Sue;
Thomas, Julia Adeney;
Yu, Bin;
Park, Nancy;
Adolphson, Mikael S.;
Entenmann, Robert;
Sinha, Mrinalini;
Rosenbaum, Arthur Lewis;
Rossabi, Morris;
Munson, Rosaria Vignolo;
Kollander, Patricia;
Bahm, Karl F.;
Wolber, Thomas K.;
Carroll, Francis M.;
Gilbert, Bentley Brinkerhoff;
Russell, Conrad;
Deshmukh, Marion F.;
Major, J. Russell;
Cox, Jeffrey;
Gullace, Nicoletta F.;
Dreher, Nan H.;
Bacon, Ew;
Ohio Wesleyan University;
University of Chicago;
University of Chicago;
University of Texas at Austin;
Radford University;
McMaster University;
Ohio Wesleyan University;
Arizona State University;
University of Nebraska‐
Lincoln;
New York University;
Wellesley College;
Walter Reuther Library;
Ohio Wesleyan University;
Fort Lewis College;
University of Montevallo;
Newberry Library, Emeritus;
Marietta College;
University of Chicago;
Amherst College;
University of Missouri‐
Kansas City;
University of Cincinnati;
St. John's University;
University of Texas;
University of Cincinnati;
Duquesne University;
Fort Hays State University;
Ohio University;
California State University, Fullerton;
University of Dayton;
University of Wisconsin‐
Madison;
Wittenberg University;
Vassar College;
University of Oklahoma;
St. Olaf College;
Boston College;
Claremont McKenna College;
City University of New York;
Swarthmore College;
Florida Atlantic Universi;
(The Historian: a journal of history,
v.59,
1997,
pp.859-947)
-
324
-
729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis
-
Gooderham, Melinda;
Lynde, Charles;
Alam, Maryam Shayesteh;
Sadick, Neil;
Rohan, Craig A;
Werschler, William Philip;
Hebert, Adelaide A;
Laquer, Vivian T;
Sauder, Maxwell;
Del Rosso, James Q;
Rodgers, Timothy;
Tan, Ricardo;
Schleicher, Stephen;
Murrell, Dedé
e F;
Fernandez-Peñ
as, Pablo;
Reich, Adam;
Gkalpakiotis, Spyridon;
Ruiz, Juan Ruano;
Wollenberg, Andreas;
Szepietowski, Jacek C;
Sticherling, Michael;
Weyergraf, Ansgar J;
Ljubojević
Hadž
avdić
, Suzana;
Baran, Wojciech;
Vilchez, Trinidad Montero;
Eniko, Telegdy;
Sebastian, Michael;
Chaudhry, Sohail;
Lee, Zachary;
Yu, Danni;
Liu, Yi;
Waltz, Wang;
Gilbert, Jenny;
Elko-Simms, Lucinda M;
Fanton, Christie;
Jue, Charleen;
Tagliaferri, Mary;
Zalevsky, Jonathan;
Rosmarin, David;
Department of Medicine, Queen’s University , Kingston, ON , Canada;
Division of Dermatology, Department of Medicine, University of Toronto , Toronto, ON , Canada;
SimcoMed Health Ltd , Barrie, ON , Canada;
Department Of Dermatology, Weill Cornell Medicine , New York, NY , USA;
Dermatology, Boonshoft School of Medicine at Wright State University , Dayton, OH , USA;
Department of Medicine/Dermatology, University of Washington , Seattle, WA , USA;
University of Texas Health Science Center Houston , Houston, TX , USA;
First OC Dermatology Research , Fountain Valley, CA , USA;
Division of Dermatology, Department of Medicine, University of Toronto , Toronto, ON , Canada;
Lakes Dermatology and Del Rosso Dermatology Research Center , Las Vegas, NV , USA;
North Texas Center for Clinical Research , Frisco, TX , USA;
California Allergy & Asthma , Los Angeles, CA , USA;
DermDox Centers for Dermatology , Sugarloaf, PA , USA;
School of Medicine, University of Notre Dame , Sydney, NSW;
(British journal of dermatology : BJD,
v.191,
2024,
pp.ljae266.102)